Pancleus (Pantoprazole)

Pantoprazole, the active ingredient in Pancleus, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to manage gastro‑reflux disease and related acid‑related disorders in adults.

GNH USA supplies Pancleus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related conditions. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of erosive esophagitis. - Erosive gastritis and duodenal ulcers: supports ulcer healing by maintaining a less acidic gastric environment. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare neuroendocrine tumor.

Adverse reactions reported with pantoprazole vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea or abdominal discomfort. - Flatulence: excess gas production. - Constipation: reduced bowel movements. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Clostridioides difficile‑associated colitis: severe intestinal infection. - Acute interstitial nephritis: inflammation of kidney interstitium. - Severe hypersensitivity reactions: rash, angioedema, anaphylaxis. - Osteoporosis‑related fractures: increased risk with long‑term use. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Vitamin B12 deficiency: reduced absorption with prolonged therapy.

Before initiating therapy, consider patient‑specific factors and monitor appropriately. - Assess renal function: dose adjustment may be required in severe impairment. - Evaluate hepatic status: use with caution in moderate to severe liver disease. - Review concomitant medications: potential for interaction with drugs requiring gastric acidity. - Monitor long‑term users: watch for bone density loss and magnesium levels. - Pregnancy and lactation: prescribe only if benefits outweigh potential risks. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Pantoprazole may alter the absorption or metabolism of several medicines; clinical relevance varies.

Major Interactions (Avoid): - Antiretroviral protease inhibitors (e.g., atazanavir): reduced plasma concentrations. - Tyrosine kinase inhibitors (e.g., erlotinib): decreased efficacy due to higher gastric pH. - Ketoconazole and other oral antifungals: markedly reduced absorption.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation. - Methotrexate (high‑dose): reduced renal clearance; check serum levels. - Digoxin: slight increase in serum concentration; observe for toxicity. - Clopidogrel: potential reduction in antiplatelet effect; consider alternative therapy.